Synergy Pharmaceuticals Announces Positive Results in Second Phase 3 Trial of Plecanatide in Patients with CIC
July 30, 2015 at 06:07 AM EDT
Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) today announced positive top-line results from the second of two pivotal ...